tiprankstipranks
Assertio Therapeutics Inc (ASRT)
NASDAQ:ASRT
US Market
ASRT
Assertio Therapeutics
RESEARCH TOOLSreports
Want to see ASRT full AI Analyst Report?

Assertio Therapeutics (ASRT) Income Statement

1,166 Followers

Assertio Therapeutics Income Statement

Last quarter (Q4 2025), Assertio Therapeutics's total revenue was $13.54M, a decrease of -57.92% from the same quarter last year. In Q4, Assertio Therapeutics's net income was $-11.06M. See Assertio Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 118.71M$ 124.96M$ 152.07M$ 156.23M$ 111.01M
Gross Profit
$ 83.33M$ 85.73M$ 125.05M$ 137.49M$ 95.18M
Operating Expenses
$ 104.87M$ 110.21M$ 368.58M$ 98.08M$ 85.76M
Depreciation and Amortization
$ 30.00M$ 25.83M$ 28.23M$ 33.40M$ 29.11M
EBITDA
$ 12.78M$ 5.15M$ 53.17M$ 90.17M$ 38.78M
Operating Income
$ -21.54M$ -24.48M$ -243.54M$ 39.41M$ 9.42M
Other Income/Expenses
$ -8.40M$ 2.95M$ -10.52M$ -8.24M$ -9.98M
Pretax Income
$ -29.94M$ -21.53M$ -254.05M$ 31.17M$ -553.00K
Net Income
$ -29.50M$ -21.58M$ -331.94M$ 109.63M$ -1.28M
Per Share Metrics
Basic EPS
$ -4.74$ -3.45$ -70.05$ 34.95$ -0.45
Diluted EPS
$ -4.74$ -3.45$ -70.05$ 30.45$ -0.45
Weighted Average Shares Outstanding
 6.40M 6.35M 4.74M 3.13M 2.88M
Weighted Average Shares Outstanding (Diluted)
 6.40M 6.35M 4.74M 3.64M 2.88M
Currency in USD

Assertio Therapeutics Earnings and Revenue History